A new January 2026 study found that use of antibiotics during pregnancy may raise the risk of babies developing Group B Streptococcus (GBS) disease by about 30 percent within four weeks of delivery.
In this study, researchers evaluated the clinical features of group B streptococcal infections (GBS) in women who were pregnant, as well as neonatal outcomes associated with GBS infection. Among women ...
Streptococcus agalactiae (known as Group B Streptococcus, or GBS) is present in the genital tract in around one in five women. Previous research by the team at the University of Cambridge and Rosie ...
Detection of Streptococcus agalactiae (Group B Streptococcus; GBS) in the placenta is associated with an increased risk for neonatal unit (NNU) admission, according to a study published online Nov. 29 ...